MedPath

A randomized double-blind placebo-controlled, clinical trial on the effect of non-surgical periodontal therapy plus doxycycline on HbA1c in patients with type 2 diabetes mellitus (DM).

Phase 2
Conditions
periodontitis.
Periodontitis
Registration Number
IRCT2014082417587N7
Lead Sponsor
Deputy of Research Council of Dental Branch Islamic Azad University of Tehran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
24
Inclusion Criteria

patients with diabetes mellitus type II (at least 3 months before diagnosis, and A fasting blood sugar level of more than 125 mg/dl) and has periodontal disease is a chronic moderate (has a clinical attachment level of 3-4 mm) peritonitis, minimum of 16 natural teeth, and no periodontal treatment in the prior 6 months, had an glycated a hemoglobin (HbA1c) value between 7- 9 percent at screening, had reported no changes in diabetes medications within the last 3 months, were in the care of a physician for their diabetes.

Exclusion criteria: pregnancy or lactation, history of allergy to drugs used in the study; smoking; diabetes related emergency within 30 days ago; use of nonsteroidal anti-inflammatory drugs; or taking low dose daily aspirin (75-325 mg); use of immunosuppressive medications; antibiotic use; dialysis; risk of bleeding complications; the type of disease periodontal (Aggressive); a history of periodontal treatment in the previous 6 months; orthodontic treatment; using the removal prostheses; extensive dental caries; dental abscesses or infections.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Periodontal pocket. Timepoint: 15 days. Method of measurement: Periodontal probe.
Secondary Outcome Measures
NameTimeMethod
Glycated hemoglobin (HbA1c). Timepoint: 3 months. Method of measurement: Blood test.
© Copyright 2025. All Rights Reserved by MedPath